-
DERMATLAS__Hidradenoma_papilliferum_RNAseq
Study
EGAS00001005715
-
IMCISION DNAseq
Study
EGAS00001005466
-
Cancer immune control needs senescence induction by Stat1 dependent cell cycle regulator pathways in tumours
Study
EGAS00001004151
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
Transcriptional changes in GBM through therapy
Study
EGAS00001003790
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Single-cell RNA-seq data of the tumor microenvironment of lymphocyte-rich Hodgkin lymphoma and other Hodgkin lymphoma subtypes
Study
EGAS00001005541
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit - 10x Genomics scRNAseq
Study
EGAS00001005098
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
Whole genome sequencing of multiple myeloma identifies novel structural and non-coding mutations.
Study
EGAS00001003164
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_RNA
Study
EGAS00001005800
-
Integrative molecular analysis of pediatric Anaplastic large cell lymphoma reveals subtypes with distinct immune suppression signatures.
Study
EGAS00001004189
-
Analysis of exonic somatic variants in light-chain amyloidosis (ALA) and ALA concomitant with multiple myeloma
Study
EGAS00001004214
-
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
Study
EGAS00001004235
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
Multiplexed quantification of four neuroblastoma DNA targets in a single droplet digital PCR reaction
Study
EGAS00001004275
-
Single-nuclei gene-expression analysis of pheochromocytoma and paraganglioma links tumor subtypes with tumor microenvironment
Study
EGAS00001005861
-
Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma
Study
EGAS00001004266
-
Analysis of IDHwt-glioblastoma samples from paired primary and recurrent tumor samples
Study
EGAS00001003184